A prediction model to identity cancer patients (pts) with febrile neutropenia (FN) at low risk to develop a serious medical complication: Results from a multinational survey conducted by the infection study section of the Multinational Association for Supportive Care in Cancer (MASCC)

被引：0
|
作者：
Klastersky, J [1 ]
机构：
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
674O
引用
收藏
页码：140 / 140
页数：1
相关论文
共 23 条
  • [21] EMERGENCY AMBULATORY MANAGEMENT OF LOW-RISK FEBRILE NEUTROPENIA: MULTINATIONAL ASSOCIATION FOR SUPPORTIVE CARE IN CANCER FITS-REAL-WORLD EXPERIENCE FROM A UK CANCER CENTER
    Marshall, William
    Campbell, Gerry
    Knight, Thomas
    Al-Sayed, Tamer
    Cooksley, Tim
    JOURNAL OF EMERGENCY MEDICINE, 2020, 58 (03): : 444 - 448
  • [22] Prediction of outcome in cancer patients with febrile neutropenia:: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10
    Uys, A.
    Rapoport, B. L.
    Fickl, H.
    Meyer, P. W. A.
    Anderson, R.
    EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (06) : 475 - 483
  • [23] Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
    Rapoport, Bernardo L.
    Shannon, Vickie R.
    Cooksley, Tim
    Johnson, Douglas B.
    Anderson, Lindsay
    Blidner, Ada G.
    Tintinger, Gregory R.
    Anderson, Ronald
    FRONTIERS IN PHARMACOLOGY, 2021, 12
123